KYMERA THERAPEUTICS, INC. — Cash Flow Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-12.2% -$10M
$-89M
Free Cash Flow↓-12.1% -$10M
$-89M
Investing Cash Flow↓-393.8% -$191M
$-143M
Financing Cash Flow↑+7174.8% +$19M
$19M
Capex↓-7.1% -$33K
$434K
Stock-Based Comp↑+12.5% +$2M
$16M
D&A↓-1.3% -$26K
$2M
SBC Allocated Expense↑+12.5% +$2M
$16M